Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial ResultsBusiness Wire • 04/15/24
Novo Integrated Sciences Provides Update on Certain Current Actions and EventsBusiness Wire • 03/26/24
Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.Business Wire • 02/21/24
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory NoteBusiness Wire • 02/20/24
Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial ResultsBusiness Wire • 01/22/24
Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated SciencesBusiness Wire • 12/19/23
Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. IndiaBusiness Wire • 12/05/23
Novo Integrated Sciences' Purchase and Sale Agreement to Acquire Ophir Collection Receives Court ApprovalBusiness Wire • 12/04/23
Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price RequirementBusiness Wire • 11/24/23
Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business DaysBusiness Wire • 11/06/23
Novo Integrated Sciences Announces Issuance of Underlying One Billion Dollar Gold Backed BondBusiness Wire • 11/03/23
Novo Integrated Sciences' Board of Directors Approves $5 Million Stock Repurchase ProgramBusiness Wire • 10/24/23
Novo Integrated stock more than doubles after hours on $1 billion collateral agreementMarket Watch • 09/28/23
Novo Integrated Sciences' IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkey's Ministry of HealthBusiness Wire • 09/13/23